Current Research Interests:
Ms. Hsu primarily collaborates on projects in the area of colorectal cancer prevention involving the Adenoma Prevention with Celecoxib (APC) placebo-controlled clinical trial, with Dr. Zauber. She has worked on projects that explore the importance of genetic variants of NSAID metabolizing enzymes for dose-related anti-tumor response or toxicity related to celecoxib. She is currently involved with planned secondary analyses examining the use of statin drugs and other concomitant medications on the risk of adenoma recurrence.
Ms. Hsu also collaborates on numerous clinical projects with members of the department within the breast, lung, and gastrointestinal services, as well as within the department of radiation oncology. Ms. Hsu's research interests include methods for survival analysis particularly for data with interval censoring, time-dependent and repeated measurements. She is also interested in the assessment of appropriate endpoints for clinical trials.
Selected Bibliography:
- Chan AT, Zauber AG, Hsu M, Breazna A, Hunter DJ, Rosenstein RB, Eagle CJ, Hawk ET, Bertagnolli MM. Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology 2009 Jun;136(7):2127-2136
- Riely GJ, Kris MG, Rosenbaum D, Marks J, Li A, Chitale DA, Nafa K, Riedel ER, Hsu M, Pao W, Miller VA, Ladanyi M. Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma. Clin Cancer Res;14(18) September 15, 2008
- Karam AK, Hsu M, Patil S, Traina TA, Ho, AY, Cody HS, Port ER, Morrow M, Gemignani ML. Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes. Ann. Surg. Oncol, 2009 Apr 18
